| P2093 | author name string | M O'Leary | |
| | A J Wagner | |
| | E S Kandel | |
| | N Hay | |
| | S D Conzen | |
| | K Gottlob | |
| | P Khanduri | |
| P2860 | cites work | Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc | Q24294647 |
| | Different regulation of c-Myc- and E2F-1-induced apoptosis during the ongoing cell cycle | Q40973340 |
| | Proteins of the Myc network: essential regulators of cell growth and differentiation. | Q41035974 |
| | Induction of DNA synthesis and apoptosis are separable functions of E2F-1. | Q41099375 |
| | The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. | Q41120735 |
| | Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. | Q41128352 |
| | p53 modulation of anchorage independent growth and experimental metastasis. | Q41158020 |
| | Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. | Q41414258 |
| | Mediation of c-Myc-induced apoptosis by p53. | Q41441186 |
| | Ongoing mutations in the N-terminal domain of c-Myc affect transactivation in Burkitt's lymphoma cell lines. | Q41483995 |
| | c-Myc induces the expression and activity of ornithine decarboxylase. | Q41515721 |
| | Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis | Q41661995 |
| | Overexpression of c-Myc inhibits p21WAF1/CIP1 expression and induces S-phase entry in 12-O-tetradecanoylphorbol-13-acetate (TPA)-sensitive human cancer cells | Q42471863 |
| | Dissection of c-myc domains involved in S phase induction of NIH3T3 fibroblasts | Q42798135 |
| | Clustered mutations in the second exon of the MYC gene in sporadic Burkitt's lymphoma. | Q48098429 |
| | Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. | Q53425055 |
| | Site-specific modulation of c-Myc cotransformation by residues phosphorylated in vivo. | Q53474910 |
| | Phosphorylation sites mapping in the N-terminal domain of c-myc modulate its transforming potential. | Q53476728 |
| | Transformation of murine myelomonocytic cells by myc: point mutations in v-myc contribute synergistically to transforming potential. | Q53516492 |
| | Mechanisms of apoptosis avoidance in cancer. | Q54107829 |
| | Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas | Q55670934 |
| | Myc represses the growth arrest gene gadd45 | Q58327259 |
| | Chimaeras of Myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells | Q59054505 |
| | c-Myc induces apoptosis and cell cycle progression by separable, yet overlapping, pathways | Q71405282 |
| | Inhibition of death receptor signals by cellular FLIP | Q24316446 |
| | Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis | Q24324204 |
| | Regulation of c-Myc through phosphorylation at Ser-62 and Ser-71 by c-Jun N-terminal kinase | Q28146223 |
| | Transactivation-defective c-MycS retains the ability to regulate proliferation and apoptosis | Q28292481 |
| | Induction of apoptosis in fibroblasts by c-myc protein | Q29614346 |
| | Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization | Q29614701 |
| | The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation | Q33667278 |
| | Myc-mediated transformation: the repression connection | Q33667285 |
| | Mechanisms of apoptosis by c-Myc | Q33667315 |
| | Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc. | Q33890400 |
| | c-Myc target genes involved in cell growth, apoptosis, and metabolism | Q33956988 |
| | Akt/Protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria | Q33959022 |
| | Isolation and characterization of c-myc, a cellular homolog of the oncogene (v-myc) of avian myelocytomatosis virus strain 29 | Q34055226 |
| | Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max. | Q34255569 |
| | Apoptotic cell death induced by c-myc is inhibited by bcl-2. | Q34255589 |
| | Cooperative interaction between c-myc and bcl-2 proto-oncogenes | Q34255596 |
| | Association of Myn, the murine homolog of Max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation | Q34769296 |
| | Opposite regulation of gene transcription and cell proliferation by c-Myc and Max. | Q36208087 |
| | c-Myc transactivation of LDH-A: implications for tumor metabolism and growth | Q36238451 |
| | Induction of ARF tumor suppressor gene expression and cell cycle arrest by transcription factor DMP1. | Q36455981 |
| | A link between increased transforming activity of lymphoma-derived MYC mutant alleles, their defective regulation by p107, and altered phosphorylation of the c-Myc transactivation domain | Q36553239 |
| | Ornithine decarboxylase is a mediator of c-Myc-induced apoptosis | Q36664688 |
| | Myc-mediated apoptosis is blocked by ectopic expression of Bcl-2 | Q36678903 |
| | Myc represses transcription of the growth arrest gene gas1 | Q36711272 |
| | Neoplastic transformation by the human gene N-myc | Q36839740 |
| | Definition of regions in human c-myc that are involved in transformation and nuclear localization | Q36839982 |
| | A link between c-Myc-mediated transcriptional repression and neoplastic transformation | Q37353738 |
| | c-Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II | Q37635815 |
| | Myc inhibits CCAAT/enhancer-binding protein alpha-gene expression in HIB-1B hibernoma cells through interactions with the core promoter region. | Q38292228 |
| | A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins | Q38295120 |
| | Sequence-specific transcriptional activation by Myc and repression by Max. | Q38322906 |
| | Myc and Max associate in vivo | Q38331177 |
| | Myc and Max proteins possess distinct transcriptional activities | Q39499398 |
| | c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release | Q40443976 |
| | The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max. | Q40874517 |
| P433 | issue | 16 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | acceleration | Q11376 |
| | apoptotic process | Q14599311 |
| P304 | page(s) | 6008-6018 | |
| P577 | publication date | 2000-08-01 | |
| P1433 | published in | Molecular and Cellular Biology | Q3319478 |
| P1476 | title | Induction of cell cycle progression and acceleration of apoptosis are two separable functions of c-Myc: transrepression correlates with acceleration of apoptosis | |
| P478 | volume | 20 | |